Noritate
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
General Information
Noritate (metronidazole cream) 1% has been approved as a topical
rosacea therapy for the treatment of inflammatory lesions and
erythema (facial redness) associated with the condition.
Clinical Results
Noritate has been shown to significantly reduce inflammatory
lesions of rosacea in as little as four weeks with minimal skin
dryness and irritation.
